Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue
about
P2X7 Cell Death Receptor Activation and Mitochondrial Impairment in Oxaliplatin-Induced Apoptosis and Neuronal Injury: Cellular Mechanisms and In Vivo ApproachP2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATPIn pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization.Role of spinal P2Y6 and P2Y11 receptors in neuropathic pain in rats: possible involvement of glial cells.Antagonist selective modulation of adenosine A1 and A3 receptor pharmacology by the food dye Brilliant Black BN: evidence for allosteric interactionsContributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat.Estrogen modulation of peripheral pain signal transduction: involvement of P2X(3) receptors.Increased local concentration of complement C5a contributes to incisional pain in mice.Activation and regulation of purinergic P2X receptor channelsP2X3 receptors and peripheral pain mechanisms.Purinoceptors as therapeutic targets for lower urinary tract dysfunction.Crossing the pain barrier: P2 receptors as targets for novel analgesics.Prostaglandin E2 potentiation of P2X3 receptor mediated currents in dorsal root ganglion neuronsP2X purinergic receptor ligands: recently patented compounds.P2X receptor antagonists for pain management: examination of binding and physicochemical properties.P2X receptors as drug targets.Calcium-permeable ion channels in pain signaling.P2X7 receptor inhibition attenuated sympathetic nerve sprouting after myocardial infarction via the NLRP3/IL-1β pathway.P2X3 antagonists: novel therapeutics for afferent sensitization and chronic pain.Characterization of three diaminopyrimidines as potent and selective antagonists of P2X3 and P2X2/3 receptors with in vivo efficacy in a pain model.Regulation of GABA(A) receptor dynamics by interaction with purinergic P2X(2) receptors.AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.Electrophysiological characterization of recombinant and native P2X receptors.Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration.Downregulation of P2X3 receptor-dependent sensory functions in A/J inbred mouse strain.Spontaneous firing and evoked responses of spinal nociceptive neurons are attenuated by blockade of P2X3 and P2X2/3 receptors in inflamed rats.Purinergic component of mechanosensory transduction is increased in a rat model of colitis.P2X receptor ligands and pain.
P2860
Q28534383-013A95E5-B3AC-4ABB-B157-94BE0598D16FQ28585703-C651F139-2EAD-4501-80E6-8F5669978BA0Q30409620-4CDF4588-206D-4C54-B475-D1765B017A3BQ33690286-DA367DA4-1925-4BE2-B8C1-8558291627F6Q33754822-7DF856BE-DA28-45C2-9090-DAB8B0AAD031Q34217715-FAC9512E-FC9E-4025-B66F-E30E431BD308Q34431207-545AB6C4-9696-4899-8F9D-C603F782EF11Q34868452-B00D8CFA-7084-4673-8155-0703E3D0A636Q35121657-A2F34A14-4CF7-46B1-A939-719016303F6DQ35122793-69657E13-E066-4F4B-8084-C0FFB18E4B4EQ35165495-83202C44-7412-4588-9451-49AAF5143196Q35545723-52427F49-7B1D-4FE9-8E38-68D2C4C7B387Q35545775-A159342F-6CAD-4256-A687-0175050149F7Q36116683-2A38F9B2-6D14-459B-A1DC-CC8D19999E4AQ37703255-885C05F1-CA11-4FE3-95C2-5B56BAD725B5Q37956570-219523C8-EEBB-4B43-B0A3-F45619BBCF35Q38068620-6FB522B0-73A6-42FE-8671-D0037F3D49ECQ38175134-54A46DDE-7C0B-403C-9B7C-17DE3B4570B1Q38805353-3696EB55-5A3A-4C2A-B195-EA188714BFB2Q39248588-22387E65-A3D0-4746-A172-CAC0BF907715Q39575365-F178A9E0-128D-46B2-9240-34AD507C2568Q39587921-774783CC-8E76-465F-A14A-2EFD0AC3EFE1Q41818439-2156DC44-6043-4F31-8EB7-E0BBF498748FQ42721794-1BB6D26C-8FE3-42C6-B35C-7B214BDE6774Q43162171-6E6435CE-86A0-43AE-840C-60D2A416FF6FQ44004715-6FF3FF47-79E6-471B-ADD3-66D2BABA6A7DQ44849910-F5286D03-D545-4749-B1DB-B8AC0AD31750Q45032136-5E2F6673-D506-4FD9-874A-37068CC3D8B7Q48460330-CBF1E4D8-5B01-48A3-9306-FBCCEC60695D
P2860
Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Modulation of BzATP and formal ...... teric modulator, cibacron blue
@ast
Modulation of BzATP and formal ...... teric modulator, cibacron blue
@en
Modulation of BzATP and formal ...... teric modulator, cibacron blue
@nl
type
label
Modulation of BzATP and formal ...... teric modulator, cibacron blue
@ast
Modulation of BzATP and formal ...... teric modulator, cibacron blue
@en
Modulation of BzATP and formal ...... teric modulator, cibacron blue
@nl
prefLabel
Modulation of BzATP and formal ...... teric modulator, cibacron blue
@ast
Modulation of BzATP and formal ...... teric modulator, cibacron blue
@en
Modulation of BzATP and formal ...... teric modulator, cibacron blue
@nl
P2093
P2860
P356
P1476
Modulation of BzATP and formal ...... teric modulator, cibacron blue
@en
P2093
C T Wismer
E A Kowaluk
E C Burgard
E Schweitzer
M F Jarvis
van Biesen T
P2860
P304
P356
10.1038/SJ.BJP.0703793
P407
P577
2001-01-01T00:00:00Z